Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Wayne Website

Alan S. Wayne, M.D.

Selected Publications
1)  Wei H, Bera TK, Wayne AS, Xiang L, Colantonio S, Chertov O, Pastan I.
A Modified Form of Diphthamide Causes Immunotoxin Resistance in a Lymphoma Cell Line with a Deletion of the WDR85 Gene.
J. Biol. Chem. 288: 12305-12, 2013. [Journal]
2)  Moriyama B, Jarosinski PF, Figg WD, Henning SA, Danner RL, Penzak SR, Wayne AS, Walsh TJ.
Pharmacokinetics of intravenous voriconazole in obese patients: implications of CYP2C19 homozygous poor metabolizer genotype.
Pharmacotherapy. 33: e19-22, 2013. [Journal]
3)  Haso W, Lee DW, Shah NN, Stetler-Stevenson M, Yuan CM, Pastan IH, Dimitrov DS, Morgan RA, FitzGerald DJ, Barrett DM, Wayne AS, Mackall CL, Orentas RJ.
Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia.
Blood. 121: 1165-74, 2013. [Journal]
4)  Mehta N, Wayne AS, Kim YH, Hale GA, Alvarado CS, Myskowski P, Jaffe ES, Busam KJ, Pulitzer M, Zwerner J, Horwitz S.
Bexarotene is active against subcutaneous panniculitis-like T-cell lymphoma in adult and pediatric populations.
Clin Lymphoma Myeloma Leuk. 12: 20-5, 2012. [Journal]
5)  Larochelle A, Gillette JM, Desmond R, Ichwan B, Cantilena A, Cerf A, Barrett AJ, Wayne AS, Lippincott-Schwartz J, Dunbar CE.
Bone marrow homing and engraftment of human hematopoietic stem and progenitor cells is mediated by a polarized membrane domain.
Blood. 119: 1848-55, 2012. [Journal]
6)  Candotti F, Shaw KL, Muul L, Carbonaro D, Sokolic R, Choi C, Schurman SH, Garabedian E, Kesserwan C, Jagadeesh GJ, Fu PY, Gschweng E, Cooper A, Tisdale JF, Weinberg KI, Crooks GM, Kapoor N, Shah A, Abdel-Azim H, Yu XJ, Smogorzewska M, Wayne AS, Rosenblatt HM, Davis CM, Hanson C, Rishi RG, Wang X, Gjertson D, Yang OO, Balamurugan A, Bauer G, Ireland JA, Engel BC, Podsakoff GM, Hershfield MS, Blaese RM, Parkman R, Kohn DB.
Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans.
Blood. 120: 3635-46, 2012. [Journal]
7)  Wei H, Xiang L, Wayne AS, Chertov O, Fitzgerald DJ, Bera TK, Pastan I.
Immunotoxin resistance via reversible methylation of the DPH4 promoter is a unique survival strategy.
Proc. Natl. Acad. Sci. U.S.A. 109: 6898-903, 2012. [Journal]
8)  Kantarjian H, Thomas D, Wayne AS, O'Brien S.
Monoclonal antibody-based therapies: a new dawn in the treatment of acute lymphoblastic leukemia.
J. Clin. Oncol. 30: 3876-83, 2012. [Journal]
9)  Kesserwan C, Sokolic R, Cowen EW, Garabedian E, Heselmeyer-Haddad K, Lee CC, Pittaluga S, Ortiz C, Baird K, Lopez-Terrada D, Bridge J, Wayne AS, Candotti F.
Multicentric dermatofibrosarcoma protuberans in patients with adenosine deaminase-deficient severe combined immune deficiency.
J. Allergy Clin. Immunol. 129: 762-769.e1, 2012. [Journal]
10)  Shah NN, Bacher U, Fry T, Calvo KR, Stetler-Stevenson M, Arthur DC, Kurlander R, Baird K, Wise B, Giralt S, Bishop M, Hardy NM, Wayne AS.
Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: Diagnostic and therapeutic challenges.
Am J Hematol. 87: 916-22, 2012. [Journal]
11)  Wayne AS, Radich JP.
Pretransplant MRD: the light is yellow, not red.
Blood. 120: 244-6, 2012. [Journal]
12)  Baird K, Fry TJ, Steinberg SM, Bishop MR, Fowler DH, Delbrook CP, Humphrey JL, Rager A, Richards K, Wayne AS, Mackall CL.
Reduced-intensity allogeneic stem cell transplantation in children and young adults with ultrahigh-risk pediatric sarcomas.
Biol. Blood Marrow Transplant. 18: 698-707, 2012. [Journal]
13)  Dave H, Anver MR, Butcher DO, Brown P, Khan J, Wayne AS, Baskar S, Rader C.
Restricted cell surface expression of receptor tyrosine kinase ROR1 in pediatric B-lineage acute lymphoblastic leukemia suggests targetability with therapeutic monoclonal antibodies.
PLoS ONE. 7: e52655, 2012. [Journal]
14)  Zhang H, Cui Y, Voong N, Sabatino M, Stroncek DF, Morisot S, Civin CI, Wayne AS, Levine BL, Mackall CL.
Activating signals dominate inhibitory signals in CD137L/IL-15 activated natural killer cells.
J. Immunother. 34: 187-95, 2011. [Journal]
15)  Cohen JI, Jaffe ES, Dale JK, Pittaluga S, Heslop HE, Rooney CM, Gottschalk S, Bollard CM, Rao VK, Marques A, Burbelo PD, Turk SP, Fulton R, Wayne AS, Little RF, Cairo MS, El-Mallawany NK, Fowler D, Sportes C, Bishop MR, Wilson W, Straus SE.
Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States.
Blood. 117: 5835-49, 2011. [Journal]
16)  Martin S, Gillespie A, Wolters PL, Widemann BC.
Experiences of families with a child, adolescent, or young adult with neurofibromatosis type 1 and plexiform neurofibroma evaluated for clinical trials participation at the National Cancer Institute.
Contemp Clin Trials. 32: 10-5, 2011. [Journal]
17)  Martin S, Calabrese SK, Wolters PL, Walker KA, Warren K, Hazra R.
Family Functioning and Coping Styles in Families of Children With Cancer and HIV Disease.
Clin Pediatr. [Epub ahead of print], 2011. [Journal]
18)  Sokolic R, Maric I, Kesserwan C, Garabedian E, Hanson IC, Dodds M, Buckley R, Issekutz AC, Kamani N, Shaw K, Tan B, Bali P, Hershfield MS, Kohn DB, Wayne AS, Candotti F.
Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiency.
Blood. [Epub ahead of print], 2011. [Journal]
19)  Bishop MR, Alyea EP, Cairo MS, Falkenburg JH, June CH, Kröger N, Little RF, Miller JS, Pavletic SZ, Porter DL, Riddell SR, van Besien K, Wayne AS, Weisdorf DJ, Wu RS, Giralt S.
National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committee.
Biol. Blood Marrow Transplant. 17: 443-54, 2011. [Journal]
20)  Phipps S, Buckholdt KE, Fernandez L, Wiener L, Kupst MJ, Madan-Swain A, Mullins L, Robert R, Sahler OJ, Vincent N, Noll RB.
Pediatric oncologists' practices of prescribing selective serotonin reuptake inhibitors (SSRIs) for children and adolescents with cancer: A multi-site study.
Pediatr Blood Cancer. [Epub ahead of print], 2011. [Journal]
21)  Wiener L, Battles H, Mamalian C, Zadeh S.
ShopTalk: a pilot study of the feasibility and utility of a therapeutic board game for youth living with cancer.
Support Care Cancer. 19: 1049-54, 2011. [Journal]
22)  Wiener LS, Kohrt BA, Battles HB, Pao M.
The HIV experience: youth identified barriers for transitioning from pediatric to adult care.
J Pediatr Psychol. 36: 141-54, 2011. [Journal]
23)  Mullins LL, Wolfe-Christensen C, Chaney JM, Elkin TD, Wiener L, Hullmann SE, Fedele DA, Junghans A.
The relationship between single-parent status and parenting capacities in mothers of youth with chronic health conditions: the mediating role of income.
J Pediatr Psychol. 36: 249-57, 2011. [Journal]
24)  FitzGerald DJ, Wayne AS, Kreitman RJ, Pastan I.
Treatment of hematologic malignancies with immunotoxins and antibody-drug conjugates.
Cancer Res. 71: 6300-9, 2011. [Journal]
25)  Jasper GA, Arun I, Venzon D, Kreitman RJ, Wayne AS, Yuan CM, Marti GE, Stetler-Stevenson M.
Variables affecting the quantitation of CD22 in neoplastic B cells.
Cytometry B Clin Cytom. 80: 83-90, 2011. [Journal]
26)  Wayne AS, Kreitman RJ, Findley HW, Lew G, Delbrook C, Steinberg SM, Stetler-Stevenson M, Fitzgerald DJ, Pastan I.
Anti-CD22 immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-positive hematologic malignancies of childhood: preclinical studies and phase I clinical trial.
Clin. Cancer Res. 16: 1894-903, 2010. [Journal]
27)  Jegalian AG, Buxbaum NP, Facchetti F, Raffeld M, Pittaluga S, Wayne AS, Jaffe ES.
Blastic plasmacytoid dendritic cell neoplasm in the pediatric population: diagnostic features and clinical implications.
Haematologica. 95: 1873-9, 2010. [Journal]
28)  Mussai F, Campana D, Bhojwani D, Stetler-Stevenson M, Steinberg SM, Wayne AS, Pastan I.
Cytotoxicity of the anti-CD22 immunotoxin HA22 (CAT-8015) against paediatric acute lymphoblastic leukaemia.
Br. J. Haematol. 150: 352-8, 2010. [Journal]
29)  Wayne AS, Baird K, Egeler RM.
Hematopoietic stem cell transplantation for leukemia.
Pediatr. Clin. North Am. 57: 1-25, 2010. [Journal]
30)  Morisot S, Wayne AS, Bohana-Kashtan O, Kaplan IM, Gocke CD, Hildreth R, Stetler-Stevenson M, Walker RL, Davis S, Meltzer PS, Wheelan SJ, Brown P, Jones RJ, Shultz LD, Civin CI.
High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemias.
Leukemia. 24: 1859-66, 2010. [Journal]
31)  Capitini CM, Mackall CL, Wayne AS.
Immune-based therapeutics for pediatric cancer.
Expert Opin Biol Ther. 10: 163-78, 2010. [Journal]
32)  Wayne AS, Capitini CM, Mackall CL.
Immunotherapy of childhood cancer: from biologic understanding to clinical application.
Curr. Opin. Pediatr. 22: 2-11, 2010. [Journal]
33)  Bishop MR, Alyea EP, Cairo MS, Falkenburg JH, June CH, Kröger N, Little RF, Miller JS, Pavletic SZ, Porter D, Riddell SR, van Besien K, Wayne AS, Weisdorf DJ, Wu R, Giralt S.
Introduction to the reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.
Biol. Blood Marrow Transplant. 16: 563-4, 2010. [Journal]
34)  Raygada M, Arthur DC, Wayne AS, Rennert OM, Toretsky JA, Stratakis CA.
Juvenile xanthogranuloma in a child with previously unsuspected neurofibromatosis type 1 and juvenile myelomonocytic leukemia.
Pediatr Blood Cancer. 54: 173-5, 2010. [Journal]
35)  El-Mallawany NK, Geller L, Bollard CM, Wistinghausen B, Mussai F, Wayne AS, Alobeid B, Cairo MS.
Long-term remission in a child with refractory EBV(+) hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV(+)-related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy.
Bone Marrow Transplant. 46: 759-61, 2010. [Journal]
36)  Kröger N, Bacher U, Bader P, Böttcher S, Borowitz MJ, Dreger P, Khouri I, Olavarria E, Radich J, Stock W, Vose JM, Weisdorf D, Willasch A, Giralt S, Bishop MR, Wayne AS.
NCI First International Workshop on the Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse Following Allogeneic Stem Cell Transplantation. Part II: Chronic Leukemias, Myeloproliferative Neoplasms and Lymphoid Malignancies.
Biol Blood Marrow Transplant. 16: 1325-46, 2010. [Journal]
37)  Porter DL, Alyea EP, Antin JH, Delima M, Estey E, Falkenburg JH, Hardy N, Kroeger N, Leis J, Levine J, Maloney DG, Peggs K, Rowe JM, Wayne AS, Giralt S, Bishop MR, van Besien K.
NCI First International Workshop on the Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant. 16: 1467-503, 2010. [Journal]
38)  Kröger N, Bacher U, Bader P, Böttcher S, Borowitz MJ, Dreger P, Khouri I, Macapintac H, Olavarria E, Radich J, Stock W, Vose JM, Weisdorf D, Willasch A, Giralt S, Bishop MR, Wayne AS.
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods, acute leukemias, and myelodysplastic syndromes.
Biol. Blood Marrow Transplant. 16: 1187-211, 2010. [Journal]
39)  Dunleavy K, Little RF, Pittaluga S, Grant N, Wayne AS, Carrasquillo JA, Steinberg SM, Yarchoan R, Jaffe ES, Wilson WH.
The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma.
Blood. 115: 3017-24, 2010. [Journal]
40)  Wayne AS.
Application of immunotherapy in pediatric leukemia.
Curr Hematol Malig Rep. 4: 159-66, 2009. [Journal]
41)  Baird K, Wayne AS.
Extracorporeal photo-apheresis for the treatment of steroid-resistant graft versus host disease.
Transfus. Apher. Sci. 41: 209-16, 2009. [Journal]
42)  Abbatiello SE, Pan YX, Zhou M, Wayne AS, Veenstra TD, Hunger SP, Kilberg MS, Eyler JR, Richards NG, Conrads TP.
Mass spectrometric quantification of asparagine synthetase in circulating leukemia cells from acute lymphoblastic leukemia patients.
Journal of proteomics. 71: 61-70, 2008. [Journal]
43)  Wayne AS, Reaman GH, Helman LJ.
Progress in the curative treatment of childhood hematologic malignancies.
J. Natl. Cancer Inst. 100: 1271-3, 2008. [Journal]
44)  Rau R, Fitzhugh CD, Baird K, Cortez KJ, Li L, Fischer SH, Cowen EW, Balow JE, Walsh TJ, Cohen JI, Wayne AS.
Triad of severe abdominal pain, inappropriate antidiuretic hormone secretion, and disseminated varicella-zoster virus infection preceding cutaneous manifestations after hematopoietic stem cell transplantation: utility of PCR for early recognition and therapy.
Pediatr. Infect. Dis. J. 27: 265-8, 2008. [Journal]
45)  Ise T, Nagata S, Kreitman RJ, Wilson WH, Wayne AS, Stetler-Stevenson M, Bishop MR, Scheinberg DA, Rassenti L, Kipps TJ, Kyle RA, Jelinek DF, Pastan I.
Elevation of soluble CD307 (IRTA2/FcRH5) protein in the blood and expression on malignant cells of patients with multiple myeloma, chronic lymphocytic leukemia, and mantle cell lymphoma.
Leukemia. 21: 169-74, 2007. [Journal]
46)  Wiener LS, Steffen-Smith E, Fry T, Wayne AS.
Hematopoietic stem cell donation in children: a review of the sibling donor experience.
Journal of psychosocial oncology. 25: 45-66, 2007. [Journal]
47)  Wayne AS, Kreitman RJ, Pastan I.
Monoclonal antibodies and immunotoxins as new therapeutic agents for childhood acute lymphoblastic leukemia. American Society of Clinical Oncology 2007 Educational Book (American Society of Clinical Oncology).
. p. 596-601. [Meeting Proceeding]
48)  Fadeyi EA, De Los Angeles Muniz M, Wayne AS, Klein HG, Leitman SF, Stroncek DF.
The transfusion of neutrophil-specific antibodies causes leukopenia and a broad spectrum of pulmonary reactions.
Transfusion. 47: 545-50, 2007. [Journal]
49)  Paz-Priel I, Long L, Helman LJ, Mackall CL, Wayne AS.
Thromboembolic events in children and young adults with pediatric sarcoma.
J. Clin. Oncol. 25: 1519-24, 2007. [Journal]
50)  Stratton P, Turner ML, Childs R, Barrett J, Bishop M, Wayne AS, Pavletic S.
Vulvovaginal chronic graft-versus-host disease with allogeneic hematopoietic stem cell transplantation.
Obstetrics and gynecology. 110: 1041-9, 2007. [Journal]
51)  Couriel D, Carpenter PA, Cutler C, Bolaños-Meade J, Treister NS, Gea-Banacloche J, Shaughnessy P, Hymes S, Kim S, Wayne AS, Chien JW, Neumann J, Mitchell S, Syrjala K, Moravec CK, Abramovitz L, Liebermann J, Berger A, Gerber L, Schubert M, Filipovich AH, Weisdorf D, Schubert MM, Shulman H, Schultz K, Mittelman B, Pavletic S, Vogelsang GB, Martin PJ, Lee SJ, Flowers ME.
Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report.
Biol. Blood Marrow Transplant. 12: 375-96, 2006. [Journal]
52)  Pao M, Ballard ED, Rosenstein DL, Wiener L, Wayne AS.
Psychotropic medication use in pediatric patients with cancer.
Archives of pediatrics & adolescent medicine. 160: 818-22, 2006. [Journal]
53)  Yamashita K, Horwitz ME, Kwatemaa A, Nomicos E, Castro K, Sokolic R, Foster SF, Garofalo M, Choi U, Ryherd M, Brown MR, Leitman SF, Wayne AS, Fowler DH, Bishop MR, Childs RW, Barrett AJ, Pavletic SZ, Malech HL.
Unique abnormalities of CD4(+) and CD8(+) central memory cells associated with chronic graft-versus-host disease improve after extracorporeal photopheresis.
Biol. Blood Marrow Transplant. 12: 22-30, 2006. [Journal]
54)  Grupp SA, June CH, Wayne AS.
Cellular immunity against cancer: has it finally arrived? American Society of Clinical Oncology 2005 Educational Book (American Society of Clinical Oncology).
. p. 759-769. [Meeting Proceeding]
55)  Strouse JJ, Fears TR, Tucker MA, Wayne AS.
Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database.
J. Clin. Oncol. 23: 4735-41, 2005. [Journal]
56)  Zarzour W, Kleta R, Frangoul H, Suwannarat P, Jeong A, Kim SY, Wayne AS, Gunay-Aygun M, White J, Filipovich AH, Gahl WA.
Two novel CHS1 (LYST) mutations: clinical correlations in an infant with Chediak-Higashi syndrome.
Mol. Genet. Metab. 85: 125-32, 2005. [Journal]
57)  Godder K, Eapen M, Laver JH, Zhang MJ, Camitta BM, Wayne AS, Gale RP, Doyle JJ, Yu LC, Chen AR, Garvin JH, Sandler ES, Yeager AM, Edwards JR, Horowitz MM.
Autologous hematopoietic stem-cell transplantation for children with acute myeloid leukemia in first or second complete remission: a prognostic factor analysis.
J. Clin. Oncol. 22: 3798-804, 2004. [Journal]
58)  Bolan CD, Yau YY, Cullis HC, Horwitz ME, Mackall CL, Barrett AJ, Malech HL, Rehak NN, Wayne AS, Leitman SF.
Pediatric large volume leukapheresis: a single institution experience with heparin versus citrate-based anticoagulant regimens.
Transfusion. 44: 229-238, 2004. [Journal]
59)  Robinson MR, Lee SS, Rubin BI, Wayne AS, Pavletic SZ, Bishop MR, Childs R, Barrett AJ, Csaky KG.
Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease.
Bone Marrow Transplantation. 33: 1031-1035, 2004. [Journal]
60)  Wayne AS, Barrett AJ.
Allogeneic hematopoietic stem cell transplantation for myeloproliferative disorders and myelodysplastic syndromes.
Hematol. Oncol. Clin. North Am. 17: 1243-60, 2003. [Journal]
61)  Khuu HM, Cowley H, David-Ocampo V, Carter CS, Kasten-Sportes C, Wayne AS, Solomon SR, Bishop MR, Childs RM, Read EJ.
Catastrophic failures of freezing bags for cellular therapy products: description, cause, and consequences.
Cytotherapy. 4: 539-49, 2002. [Journal]
62)  Tangsinmankong N, Wayne AS, Howenstine MS, Washington KR, Langston C, Gatti RA, Good RA, Nelson RP.
Lymphocytic interstitial pneumonitis, elevated IgM concentration, and hepatosplenomegaly in ataxia-telangiectasia.
J. Pediatr. 138: 939-41, 2001. [Journal]
63)  Wayne AS, Schoenike SE, Pegelow CH.
Financial analysis of chronic transfusion for stroke prevention in sickle cell disease.
Blood. 96: 2369-72, 2000. [Journal]
64)  Walters MC, Storb R, Patience M, Leisenring W, Taylor T, Sanders JE, Buchanan GE, Rogers ZR, Dinndorf P, Davies SC, Roberts IA, Dickerhoff R, Yeager AM, Hsu L, Kurtzberg J, Ohene-Frempong K, Bunin N, Bernaudin F, Wong WY, Scott JP, Margolis D, Vichinsky E, Wall DA, Wayne AS, Pegelow C, Redding-Lallinger R, Wiley J, Klemperer M, Mentzer WC, Smith FO, Sullivan KM.
Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease.
Blood. 95: 1918-24, 2000. [Journal]
65)  Weitzman S, Wayne AS, Arceci R, Lipton JM, Whitlock JA.
Nucleoside analogues in the therapy of Langerhans cell histiocytosis: a survey of members of the histiocyte society and review of the literature.
Med. Pediatr. Oncol. 33: 476-81, 1999. [Journal]
66)  Walters MC, Patience M, Leisenring W, Rogers ZR, Dinndorf P, Davies SC, Roberts IA, Yeager A, Kurtzberg J, Bunin N, Scott JP, Wall DA, Wayne AS, Wiley J, Darbyshire PJ, Mentzer WC, Smith FO, Sullivan KM.
Collaborative multicenter investigation of marrow transplantation for sickle cell disease: current results and future directions.
Biol. Blood Marrow Transplant. 3: 310-5, 1997. [Journal]
67)  Busque L, Gilliland DG, Prchal JT, Sieff CA, Weinstein HJ, Sokol JM, Belickova M, Wayne AS, Zuckerman KS, Sokol L.
Clonality in juvenile chronic myelogenous leukemia.
Blood. 85: 21-30, 1995. [Journal]
68)  de la Morena MT, Wayne AS, Day NK, Haag MM, Hinds-Frey KR, Nelson RP, Sutcliffe MJ, Good RA.
Recipient T-cell immune reconstitution in X-linked SCID after haploidentical maternal bone marrow transplant.
Ann. N. Y. Acad. Sci. 770: 376-7, 1995. [Journal]
69)  Olivieri NF, Nathan DG, MacMillan JH, Wayne AS, Liu PP, McGee A, Martin M, Koren G, Cohen AR.
Survival in medically treated patients with homozygous beta-thalassemia.
N. Engl. J. Med. 331: 574-8, 1994. [Journal]
70)  Bhattacharyya N, Wayne AS, Kevy SV, Shamberger RC.
Perioperative management for cholecystectomy in sickle cell disease.
J. Pediatr. Surg. 28: 72-5, 1993. [Journal]
71)  West DC, Shamberger RC, Macklis RM, Kozakewich HP, Wayne AS, Kreissman SG, Korf BR, Lavally B, Grier HE.
Stage III neuroblastoma over 1 year of age at diagnosis: improved survival with intensive multimodality therapy including multiple alkylating agents.
J. Clin. Oncol. 11: 84-90, 1993. [Journal]
72)  Wayne AS, Zelicof SB, Sledge CB.
Total hip arthroplasty in beta-thalassemia. Case report and review of the literature.
Clin. Orthop. Relat. Res. 149-54, 1993. [Journal]
73)  Wayne AS, Kevy SV, Nathan DG.
Transfusion management of sickle cell disease.
Blood. 81: 1109-23, 1993. [Journal]
Click Here to View Collapsed Bibliography.

This page was last updated on 5/9/2013.